LRP1B and hepatocellular carcinoma: Thus, the presence of LRP1B mutation may help in predicting HCC prognosis in those patients with higher TMB and higher expression of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2), another immune checkpoint gene.